CSI Market
Sign In | Register

Karyopharm Therapeutics Inc (KPTI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access KPTI Annual Balance Sheets →
This page allows investors to track Karyopharm Therapeutics Inc's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent65.10
Available-for-sale Securities, Debt Securities, Current MA10.13
Cash & Short-term Investments75.00
Accounts receivable29.87
Inventories3.99
Prepaid Expense And Other Assets Current7.41
Total Current Assets106.38
Equipment/Property/Plant Net0.09
Long-term investments0.32
Other Assets, Noncurrent4.53
Operating Lease Right Of Use Asset4.41
Total Assets111.32
Liabilities
Accounts Payable, Current AC7.66
Accrued Liabilities, Current AC78.80
Secured Debt, Current LO40.31
Other Liabilities, Current7.46
Total Current Liabilities134.23
Long-term debt85.05
Secured Debt85.05
Total Long-term Debt85.05
Other liabilities, Noncurrent222.21
Operating Lease Liability Current1.02
Convertible Senior Notes Due Two Thous and Twenty Five-
Convertible Senior Notes Due Two Thous and Twenty Nine86.25
Operating Lease Liability Noncurrent5.47
Total Liabilities441.49
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,518.69
Retained Earnings / Accumulated Deficit-1,848.91
Accumulated Other Comprehensive Income0.04
Other Equity0.04
Common Stockholder's Equity-330.17
Total Stockholder's Equity-330.17
Liabilities & Stockholder's Equity111.32
4 historic quarters locked

Sign in to unlock the full Karyopharm Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Karyopharm Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-347906

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.